text:
Sugar Allergy
Human Anatomy, Physiology, and Medicine. Anything human!
Moderator: BioTeam
DrDahlman is advertising openly on this forum with cures for potentially very serious diseases such as Crohn's and Ulcerative Colitis. Whereas Irritable Bowel Syndrome is common and non-fatal, the first two mentioned diseases are potentially serious. There are plenty of other gastrointestinal diseases which can present with very similar symptoms such as all the different causes of malabsorption syndromes, gut infections and cancers.
People should be wary of persons who advertise cures. If DrDahlman truly believes that he has found a cure or a help for these conditions then I would expect him to have written papers on the topics in question in reputable medical journals. I would be delighted if he could give me the references so that we could see whether his treatment has been through proper controlled clinical trials.
Before obtaining a Medical Degree in the UK, I trained and qualified as an Osteopath. Having experienced the limitations of "alternative medicine" I decided to enroll in Medical School.
As I suspected and predicted, now we have two folks who cannot debate the merits of my treatments, they prefer to denigrate and try to diminish me as if that then determines the value of what I propose. Let me tell you what determines the value of what I suggest to my patients: the sheer volume of them who seek out help from me.
In an earlier post I suggested that anyone concerned should contact the Ohio State Board of Chiropractic, the Ohio State Attorney General or the Better Business Bureau to check me out and my reputation. If I was fooling people or not getting the results that satisfy them...think of all the complaints that must have been filed against me. But they have not. I have had contact with more than 15,000 people via phone or email and a million almost every year who visit my websites over the last 10 years. Surely a few would have been dissatisfied. I can remember one complaint.
So, continue your attacks. I continue unconcerned. My days are filled with great reward when an 80 year old WWII vet walks into my office in a diaper, suffering Crohn's Disease and complains that I am his doctor of last resort before he asks his gastroenterologist to remove his bowels so he can stop suffering for his last few years. Three months later he is having formed bowel movements, no diaper and no accidents anymore.
I continue to carry on without either of you. You are fools who believe that all "alternative" medicine is the same. It is not and I actually agree with a previous post about how much of "alternative" medicine is a sham and can be dangerous. But your thought process fails you when you lump my version of it into the same bag.
Sort of like the most acute failure of conventional medicine to think that one molecule (drug) can end one condition (symptom) in all people of differing size, gender, race and genes. It can't and that why millions flock to anything alternative. BTW, Osteopathy in America is not considered alternative, it has been taken under the wing of the medical schools with only slight regard for the founding tenets of that discipline. If ya can't fight 'em, absorb them!
So, if you can't debate the merits of the many parts of my exact protocol, you will be lost in the incessant attacks that serve nothing but making you feel good that you have found some sort of weakness in me. You haven't, I am busier than I can actually handle anymore. Please go to http://www.DrDahlman.com , download for free any of my reports, read them and then get back to me about where they lack the sense and success of conventional medicine. That we can sink our teeth into. But you can't or would be unwilling to take the chance you are wrong.
Studies? Research? By me? Why, when the research has already been done? I'm not taking guesses here. There is more research than you could read in a lifetime about the purpose of probiotics and its effect if those levels are substandard, imbalanced gut chemistry, effects of a lack of digestive enzymes, what happens when you lose your gall bladder, the negative effects (in some people) of dairy products, gluten containing foods and how to recognize a fructose intolerance. Then there's Celiac Disease and the inflammatory cascade caused by food allergies. Provide you with research? Sir, if you had any interest in knowing that all you would have to do is put any of the above terms into a search engine and you would see. If a general search engines scares you, please use the medical search engines like MedScape or MedLine.
Oh, what the heck...here, I'll do some research for you:
1. Horwittz BJ, Fisher RS. The irritable bowel syndrome. New Engl J Med 2001;344(24):1846-50.
2. Mayer EA. Emerging disease model for functional gastrointestinal disorders. Am J Med 1999;107(5A):12S-19S.
3. Mielants H, De Vos M, Goemaere S, et al. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease. J Rheumatol 1991;18(3):394-400.
4. Smith M, Gibson R, Brooks P. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 1985;12(2):299-305.
5. Andre C, Andre F, Colin L. Effect of allergen ingestion challenge with and without cromoglycate cover on intestinal permeability in atopic dermatitis, urticaria, and other symptoms of food allergy. Allergy 1989;44 (Suppl 9):47-51.
6. Isolauri E, Juntunen M, Wiren S. Intestinal permeability changed in acute gastroenteritis: effects of clinical factors and nutritional management. J Pediatr Gastroenterol Nutr 1989;8(4):466-73.
7. Munkholm P, Langholz E, Hollander D, et al. Intestinal permeability in patients with Crohn?s disease and ulcerative colitis and their first degree relatives. Gut 1994;35(1):68-72.
8. Olaison G, Sjodahl R, Tagesson C. Abnormal intestinal permeability in Crohn?s disease. Scand J Gastroenterol 1990;25(4):321-28.
9. McCarthy DM. Comparative toxicity of nonsteroidal anti-inflammatory drugs. Am J Med 1999;107(6A):37S-46S.
10. Sicherer SH. Manifestations of food allergy: evaluation and management. Am Fam Physician 1999; 59(2):415-24, 429-30.
11. Samartín S, Marcos A, Chandra RK. Food hypersensitivity. Nutr Res 2001;21(3):473-97.
12. Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol 1999;104(3 Pt 2):S114-22.
13. Fraser AG, Woollard GA. Gastric juice ascorbic acid is related to Helicobacter pylori infection but not ethnicity. J Gastroenterol Hepatol 1999;14(11):1070-73.
14. Reed PI. Vitamin C, Helicobacter pylori infection and gastric carcinogenesis. Int J Vitam Nutr Res 1999;69(3):220-27.
15. Fleming C, Huizenga K, McCall J, et al. Zinc nutrition in Crohn?s disease. Dig Dis Sci 1991;26(10):865-70.
16. Hendricks K, Walder W. Zinc deficiency in inflammatory bowel disease. Nutr Rev 1988;46(12):401-08.
17. Tomomatsu H. Health effects of oligosaccharides. Food Tech 1994;October:61-65.
18. Gibson G, Roberfroid M. Dietary modulation of the human colonic microbiota: introducing the concept of probiotics. J Nutr 1995;125(6):1401-12.
19. Roberfroid MB. Chicory fructooligosaccharides and the gastrointestinal tract. Nutrition 2000;16(7-8):677-79.
20. Robinson R, Causey J, Slavin JL. Nutritional benefits of larch arabinogalactan. In: ed. McCleary BV, Prosky L. Advanced Dietary Fibre Technology. London: Blackwell Science; 2001:443-51.
21. Ellestad-Sayed J, Nelson R, Adson M, et al. Pantothenic acid, coenzyme A, and human chronic ulcerative and granulomatous colitis. Am J Clin Nutr 1976;29:1333-38.
22. Lacroix B, Didier E, Grenier J. Role of pantothenic and ascorbic acid in wound healing processes: in vitro study on fibroblasts. Intl J Vit Nutr Res 1988;58:507-13.
23. Lewis DA, Shaw GP. A natural flavonoid and synthetic analogues protect the gastric mucosa from aspirin-induced erosions. J Nutr Biochem 2001;12(2):85-100.
24. Mukhopadhyaya K, Bhattacharya D, Chakraborty A, et al. Effect of banana powder (Musa sapeintus var. paradisiaca) on gastric mucosal shedding. J Ethnopharmacol 1987;21(1):11-19.
25. Wakabayashi H, Orihara T, Nakaya A, et al. Effect of Helicobacter pylori infection on gastric mucosal phospholipid contents and their fatty acid composition. J Gastrenterol Hepatol 1998;13(6):566-71.
26. Kurinets A, Lichtenberger LM. Phosphatidylcholine-associated aspirin accelerates healing of gastric ulcers in rats. Dig Dis Sci 1998;43(4):786-90.
27. Anand BS, Romero JJ, Sanduja SK, et al. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am Coll Gastroenterol 1999;94(7):1818-22.
28. Ziegler TR, Bazargan N, Leader LM, et al. Glutamine and the gastrointestinal tract. Curr Opin Clin Nutr Metab Care 2000;3(5):355-62.
29. Klimberg VS, Salloum RM, Kasper M, et al. Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg 1990;125(8):1040-45.
30. Souba WW, Klimberg VS, Plumley DA, et al. The role of glutamine in maintaining a health gut and supporting the metabolic response to injury and infection. J Surgical Res 1990;48(4):383-91.
31. Cao Y, Feng Z, Hoos A, et al. Glutamine enhances gut glutathione production. J Parent Enteral Nutr 1998;22(4):224-27.
32. LeLeiko NS, Walsh MJ. The role of glutamine, short-chain fatty acids, and nucleotides in intestinal adaptation to gastrointestinal disease. Pediatr Clin North Am 1996;43(2):451-70.
33. Nakajima M, Shinoda I, Samejima Y, et al. Lactoferrin as a suppressor of cell migration of gastrointestinal cell lines. J Cell Physiol 1997;170(2):101-05.
34. Kruzel ML, Harari Y, Chen C-Y, et al. The gut: a key metabolic organ protected by lactoferrin during experimental systemic inflammation in mice. Adv Exp Med Biol 1998;443:167-73.
35. Kussendrager KD, van Hooijdonk AC. Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications. Br J Nutr 2000;84 (Suppl 1):S19-25.
36. van Hooijdonk AC, Kussendrager KD, Steijns JM. In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. Br J Nutr 2000;84 (Suppl 1):S127-34.
37. Hauer J, Anderer FE. Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis. Cancer Immunol Immunother 1993;36(4):237-44.
38. Kelly GS. Larch arabinogalactan: Clinical relevance of a novel immune-enhancing polysaccharide. Alt Med Rev. 1999;4(2):96-103.
39. Hagmar B, Ryd W, Skomedal H. Arabinogalactan blockade of experimental metastases to liver by murine hepatoma. Invasion Metastasis 1991;11(6):348-55.
40. Vince AJ, McNeil NI, Wager JD, et al, The effect of lactulose. pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation system. Br J Nutr 1990;63(1):17-26.
41. Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome. Annu Rev Med 2001;52:319-38.
42. Borum ML. Irritable bowel syndrome. Gastroenterology 2001;28(3):523-38.
43. Browning SM. Constipation, diarrhea, and irritable bowel syndrome. Prim Care 1999;26(1):113-39.
44. Schuster MM. Defining and diagnosing irritable bowel syndrome. Amer J Man Care 2001;7(Suppl):S247-51.
45. National Institute of Diabetes & Digestive & Kidney Diseases. Irritable bowel syndrome. (1992, October). Retrieved February 5, 2002, from http://www.niddk.nih.gov/health/digest/ ... rbowel.htm
46. Horwitz BJ, Fisher RS. The irritable bowel syndrome. New Engl J Med 2001;344(24);1846-50.
47. Schulz V, Hansel R, Tyler VE. Rational Phytotherapy, A Physicians? Guide to Herbal Medicine. 3rd ed. Berlin: Springer-Verlag; 1998.
48. Kline RM, Kline JJ, Di Palma J, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pedriatr 2001;138(1):125-28.
49. Liu JH, Chen GH, Yeh HZ, et al. Enteric-coated peppermint oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol 1997;32(6):765-68.
50. Hills JM, Aaronson PI. The mechanism of action of peppermint oil on gastro-intestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. Gastroenterology 1991;101(1):55-65.
51. O?Hara MA, Kiefer D, Farrell K, et al. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998;7(6):523-36.
52. Lis-Balchin M, Hart S. Studies on the mode of action of the essential oil of lavender (Lavandula angustifolia P. Miller). Phytother Res 1999;13(6):540-42.
53. Dunne C. Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis 2001;7(2):136-45.
54. Dunne C. Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis 2001;7(2):136-45.
55. Reid G. In vitro testing of Lactobacillus acidophilus NCFM as a possible probiotic for the urogenital tract. Int Dairy J 2000;10:415-19.
56. Wollowski I, Rechkemmer G, Pool-Zobel BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001;73(suppl):451S-55S.
57. Sanders ME, Klaenhammer TR. The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 2001;84:319-31.
58. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999;3(4):197-202.
59. Goldin BR, Swenson L, Dwyer J, et al. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Instit 1980;64:255-61.
60. Gilliland SE, Speck ML. Antagonistic action of Lactobacillus acidophilus toward intestinal and food borne pathogens in associative cultures. J Food Protection 1977;40(12):820-23.
61. Schauss AG. Lactobacillus acidophilus: method of action, clinical application, and toxicity data. J Adv Med 1990;3(3):163-78.
62. Lin MY, Savaiano D, Harlander S. Influence of nonfermented dairy products containing bacterial starter cultures on lactose maldigestion in humans. J Dairy Sci 1991;74:87-95.
63. Barefoot SF, Klaenhammer TR. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol 1983;45:1808-15.
64. Barefoot SF, Chen YR, Hughes TA, et al. Identification and purification of a protein that induces production of the Lactobacillus acidophilus bacteriocin lactacin B. Appl Environ Microbiol 1994;60:3522-28.
65. Goldin BR, Gorbach SL. The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Amer J Clin Nutr 1984;39:756-61.
66. Goldin BR, Gorbach SL. Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides. J Natl Cancer Instit 1984;73:689-95.
67. Goldin BR, Gorbach SL. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J Natl Cancer Instit 1980;64:263-65.
68. Simenhoff ML, Dunn SR, Zollner GP, et al. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab 1996;22:92-96.
69. Kim GS, Gilliland SE. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci 1983;66:959-66.
70. Marteau PR, de Vrese M, Cellier CJ, et al. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001;73(suppl):430S-36S.
71. Walker DK, Gilliland SE. Relationships among bile tolerance, bile salt deconjugation, and assimilation of cholesterol by Lactobacillus acidophilus. J Dairy Sci 1993;76:956-61.
72. Gilliland SE, Nelson CR, Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol 1985;49:377-81.
73. Cassell GH, Mekalanos J. Antibiotic resistance. JAMA 2001;285:601-05.
74. Tuomola E, Crittenden R, Playne M, et al. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 2001;73(suppl):393S-98S.
75. Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 1999;65(9):3763-66.
76. Gilliland SE, Walker DK. Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans. J Dairy Sci 1990;73:905-11.
77. Kleeman EG, Klaenhammer TR. Adherence of Lactobacillus species to human fetal intestinal cells. J Dairy Sci 1982;65:2063-69.
78. Montes RG, Bayless TM, Saavedra JM. Effect of milks inoculated with Lactobacillus acidophilus or a yogurt starter culture in lactose-maldigesting children. J Dairy Sci 1995;78(8):1657-64.
79. Greene JD, Klaenhammer TR. Factors involved in adherence of lactobacilli to human caco-2 cells. Appl Environ Microbiol 1994;60:4487-94.
80. Gilliland SW, Speck ML, Nauyok DF, et al. Influence of consuming nonfermented milk containing Lactobacillus acidophilus on fecal flora of healthy males. J Dairy Sci 1978;61:1-10.
81. Sanders ME, Walker DC, Walker KM, et al. Performance of commercial cultures in fluid milk applications. J Dairy Sci 1996;79:943-55.
82. Klaenhammer TR, Kleeman EG. Growth characteristics, bile sensitivity, and freeze damage in colonial variants of Lactobacillus acidophilus. Appl Environ Microbiol 1981;41:1461-67.
83. Klaenhammer TR. Microbiological considerations in selection and preparation of Lactobacillus strains for use as dietary adjuncts. J Dairy Sci 1982;65:1339-49.
84. Goldin B, Gorbach SL. Alterations in fecal microflora enzymes related to diet, age, Lactobacillus supplements, and dimethylhydrazine. Cancer 1977;40:2421-26.
85. Kaplan H, Hutkins RW. Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. Appl Environ Microbiol 2000;66(6):2682-84.
86. Rasic JLj, Kurmann JA. Bifidobacteria and Their Role. Boston: Kirkhauser Verlag; 1983.
87. Gill HS, Rutherfurd KJ, Cross ML, et al. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 2001;74(6):833-39.
88. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-12.
89. Guyton AC. Protein Metabolism. In: Textbook of Medical Physiology. 8th ed. Philadelphia: W.B. Saunders; 1991.
90. Ward PP, Uribe-Luna S, Conneely OM. Lactoferrin and host defense. Biochem Cell Biol 2002;80(1):95-102.
91. Ellison RT 3rd. The effects of lactoferrin on gram-negative bacteria. Adv Exp Med Biol 1994;357:71-90.
92. Conneely OM. Antiinflammatory activities of lactoferrin. J Am Coll Nutr 2001;20(5 Suppl):389S-97S.
93. van der Strate BW, Beljaars L, Molema G, et al. Antiviral activities of lactoferrin. Antiviral Res 2001;52(3):225-39.
94. Ajello M, Greco R, Giansanti F, et al. Anti-invasive activity of bovine lactoferrin towards group A streptococci. Biochem Cell Biol 2002;80(1):119-24.
95. Shin K, Hayasawa H, Lonnerdal B. Inhibition of Escherichia coli respiratory enzymes by the lactoperoxidase-hydrogen peroxide-thiocyanate antimicrobial system. J Appl Microbiol 2001;90(4):489-93.
96. Shin K, Yamauchi K, Teraguchi S, et al. Susceptibility of Helicobacter pylori and its urease activity to the peroxidase-hydrogen peroxide-thiocyanate antimicrobial system. J Med Microbiol 2002;51(3):231-37.
97. Borch E, Rosen C, Bjorck L. Antibacterial effect of the lactoperoxidase/thiocyanate/hydrogen peroxide system against strains of campylobacter isolated from poultry. J Food Protect 1989;42(9):639-41.
98. Thomas EL, Milligan TW, Joyner RE, et al. Antibacterial activity of hydrogen peroxide and the lactoperoxidase-hydrogen peroxide-thiocyanate system against oral streptococci. Infect Imm 1994;6(2):529-35.
99. Lengerich EJ, Addiss DG. Severe giardiasis in the United States. Clin Infec Dis 1994;18:760-63.
100. Levy SB. The challenge of antibiotic resistance. Sci Am 1998;278(3):46-53.
101. Bensky D, Gamble A. Chinese Herbal Medicine. Materia Medica. Seattle: Eastland Press; 1986.
102. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999;12(4):564-82.
103. Duke JA. Handbook of Medicinal Herbs. Boca Raton: CRC Press; 1985.
104. Shils ME, Olson JA, Shike M, et al. editors. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins; 1999.
105. Wallace JM. Nutritional modulation of gut-immune system interactions in autoimmunity. Int J Integr Med 2000;2(1):18-22.
106. Slocum MM, Sittig MD, Specian RD, et al. Absence of intestinal bile promotes bacterial translocation. Am Surg 1992;58:305-10.
107. Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353(9167):1838-42.
108. Knoke M, Bernhardt H. The impact of microbial ecology on clinical problems. Infection 1989;17(4):255-58.
109. Veys EM, Mielants H. Enteropathic arthritis, uveitis, Whipple?s disease, and miscellaneous spondyloarthropathies. Curr Opin Rheumatol 1993;5(4):420-27.
110. Gorbach SL. Estrogens, breast cancer, and intestinal flora. Rev Infect Dis 1984;6(1):S85-S90.
111. McDowell RM, McElvaine MD. Long-term sequelae of foodborne diseases. Rev Sci Tech 1997;16(2):337-41.
112. Galland L, Barrie S. Intestinal dysbiosis and the causes of disease. J Adv Med 1993;6(2):67-81.
113. Heumann D, Glauser MP. Pathogenesis of sepsis. Sci Am 1994;1:28-37.
114. Rowlands BJ, Gardiner KR. Nutritional modulation of gut inflammation. Proc Nutr Soc 1998;57(3):395-401.
115. Research on host susceptibility to emerging pathogens. (n.d.). National Institutes of Health, National Institute of Allergy and Infectious Disease. Retrieved April 3, 2000, from http://www.niaid.nih.gov/publications/execsum/3a.htm
116. Skov L, Baadsgaard O. Superantigens. Do they have a role in skin disease? Arch Dermatol 1995;131(7):829-32.
117. Torres BA, Johnson HM. Modulation of disease by superantigens. Curr Opin Immunol 1998;10(4):465-70.
118. Soos JM, Schiffenbauer J, Torres BA, et al. Superantigens as virulence factors in autoimmunity and immunodeficiency diseases. Med Hypotheses 1997;48(3):253-59.
119. Johnson HM, Torres BA, Soos JM. Superantigens:structure and relevance to human disease. Soc Exp Biol Med 1996;212:99-109.
120. Gladwin M, Trattler B. Clinical Microbiology Made Ridiculously Simple. Miami: MedMaster, Inc.; 1995.
121. Dharmananda S. Chinese Herbology: A Prefessional Training Progrram. Portland, Oregon: Institute for Traditional and Preventative Health Care; 1992.
122. Chevallier A. The Encyclopedia of Medicinal Plants. London: Dorling Kindersley Ltd.; 1996.
123. Huang KC. The Pharmacology of Chinese Herbs. Boca Raton: CRC Press; 1993.
124. Tyler VE, Brady LR, Robbers, JE. Pharmacognosy. 9th ed. Philadelphia: Lea & Febiger; 1988.
125. Wang M, Shao Y, Li J, et al. Antioxidative phenolic glycosides from sage (Salvia officinalis). J Nat Prod 1999;62(3):454-56.
126. Agnihotri S, Vaidya ADB. A novel approach to study antibacterial properties of volatile components of selected Indian medicinal herbs. Indian J Exp Biol 1996;34:712-15.
127. Tabak M, Armon R, Potaman I, et al. In vitro inhibition of Helicobacter pylori by extracts of thyme. J Appl Bacteriol 1996;80(6):667-72.
128. Smith-Palmer A, Stewart J, Fyfe L. Antimicrobial properties of plant essential oils and essences against five important food-borne pathogens. Lett Appl Microbiol 1998;26(2):118-22.
129. Hammer KA, Carson CF, Riley TV. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 1999;86(6):985-90.
130. Dorman HJ, Deans SG. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol 2000; 88(2):308-16.
131. Milhau G, Valentin A, Benoit F, et al. In vitro antimalarial activity of eight essential oils. J Essent Oil Res 1997;9:329-33.
132. Blumenthal M, BusseWR, Goldberg A, et al. editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin, Texas: American Botanical Society; 1998.
133. Kucera LS, Cohen RA, Herrmann EC. Antiviral activities of extracts of the lemon balm plant. Ann N Y Acad Sci 1965;130(1):474-82.
134. Kaneda Y, Torii M, Tanaka T, et al. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Annals Trop Med Parasitology 1991;85(4):417-25.
135. Rabbani GH, Butler T, Knight J, et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Eschericia coli and Vibrio cholerae. J Infec Dis 1987;155(5):979-84.
136. Sy ND, Hoan DB, Dung NP, et al. Treatment of malaria in Vietnam with oral artemisinin. Am J Trop Med Hyg 1993;48(3):398-402.
137. Koch HP, Lawson LD, editors. Garlic: The Science and Therapeutic Application of Allium sativum L. and Related Species. 2nd Ed. Baltimore: Williams & Wilkins; 1996.
138. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect 1999;1(2):125-29.
139. Mascolo N, Jain R, Jain SC, et al. Ethnopharmacologic investigation of ginger (Zingiber officinale). J Ethnopharmacol 1989;27:129-40.
140. Adewunni CO, Oguntimein BO, Furu P. Molluscicidal and antischistosomal activities of Zingiber officinale. Planta Med 1990;36:374-76.
141. Yamahara J, Huang Q, Li Y, et al. Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull 1990;38(2):430-31.
142. Goto C, Kasuya S, Koga K, et al. Lethal efficacy of extract from Zingiber officinale (traditional Chinese medicine) or [6]-shogaol and [6]-gingerol in Anisakis larvae in vitro. Parisitol Res 1990;76:653-56.
143. Rhee JK, Woo KJ, Baek BK, et al. Screening of the wormicidal Chinese raw drugs on Clonorchis sinensis. Am J Chin Med 1982;9(4):277-84.
144. Duthie SJ, Collins AR, Duthie GG, Dobson VL. Quercetin and myricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidised pyrimidines) in human lymphocytes. Mutat Res. 1997;393(3):223-231.
145. Ferry DR, Smith A, Malkhandi J, et al. Phase I clinical trial of the flavonoid quercetin pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996;2(4):659-668.
146. Frolov VM, Peresadin NA, Khomutianskaia NI, Pshenichnyi I. The efficacy of quercetin and tocopherol acetate in treating patients with Flexner's dysentery [in Ukrainian]. Lik Sprava. 1993;4:84-86.
147. Gross M, Pfeiffer M, Martini M, Campbell D, Slavin J, Potter J. The quantitation of metabolites of quercetin flavonols in human urine. Cancer Epidemiol Biomarkers Prevent. 1996;5(9):711-720.
148. Haas EM. Staying Healthy with Nutrition. Berkley, Calif: Celestial Arts Publishing; 1992:272, 882-884.
149. Hollman PC, Van Trijp JM, Mengelers MJ, De Vries JH, Katan, MB. Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett. 1997;114(1-2):139-140.
150. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ (Clinical Research Ed.). 1996;312(7029):478-481.
151. Murray MT. Encyclopedia of Nutritional Supplements. Rocklin, Calif: Prima Publishing; 1996: 320-321.
152. Murray MT, Pizzorno JE. Encyclopedia of Natural Medicine. 2nd ed. Rocklin, Calif: Prima Publishing; 1996:268, 314, 422, 494, 546-47, 766.
153. Shils ME, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and Disease. 9th ed. Baltimore, Md: Williams & Wilkins; 1999:1274-1277.
154. Werbach MR. Nutritional Influences on Illness. 2nd ed. Tarzana, Calif: Third Line Press; 1993:179, 259, 267, 389.
155. Young JF, Nielsen SE, Haraldsdottir J, et al. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr. 1999; 69(1):87-94.
156. Abela MB. Hypnotherapy for Crohn's disease: a promising complementary/alternative therapy. Integr Med.2000;2(2/3):127-131.
157. Alic M. Green tea for remission maintenance in Crohn's disease? Am J Gastroenterol.1999;94(6):1710
158. Anton PA. Stress and mind-body impact on the course of inflammatory bowel diseases. Semin Gastrointest Dis.1999;10(1):14-19.
159. Ball E. Exercise guidelines for patients with inflammatory bowel disease. Gastroenterol Nurs.1998;21(3):108-111.
160. Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr.2000;71(suppl):339S-342S.
161. Belluzzi A, Brignola C, Campieri M, et al. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients. Dig Dis Sci.1994;39(12):2589-2594.
162. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med.1996;334(24):1557-1560.
163. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000;231(1):38-45.
164. Blumenthal M, ed. Herbal Medicine. Expanded Commission E Monographs. Newton, Mass: OneMedicine; 2000.
165. Bock S. Integrative medical treatment of inflammatory bowel disease. Int J Integr Med. 2000;2(5):21-29.
166. Bousvaros A, Zurakowski D, Duggan C. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr . 1998;26:129-135.
167. Brignola C, Belloli C, De Simone G, et al. Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn's disease. Aliment Pharmacol Ther. 1993;7:275-280.
168. Chowers Y, Sela B, Holland R, Fidder H, Simoni FB, Bar-Meir S. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol. 2000;95(12):3498-3502.
169. Colombel J, Mathieu D, Bouault J, Lesage X, Zavadil P, Quandelle P, Cortot A. Hyperbaric oxygenation in severe perineal Crohn's disease. Dis Colon Rectum. 1995;38:609-614.
170. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 2001;120(5):1093-1099.
171. Crohn's and Colitis Foundation of America. News Updates. Entocortä EC (budesonide) for Crohn's disease approved by the FDA. October 3, 2001. Accessed at http://www.ccfa.org/news/entocort.htm on October 15, 2001.
172. Dear KL, Hunter JO. Colonoscopic hydrostatic balloon dilation of Crohn's strictures. J Clin Gastroenterol. 2001;33(4):315-318.
173. Farmer M, Petras RE, Hunt LE, Janosky JE, Galadiuk S. The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am J Gastroenterol. 2000; 95(11):3184-3188.
174. Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal ß-D-Galactosidase production and Bifidobacteriaare decreased in Crohn's disease. Dig Dis Sci.1997;42(4):817-822.
175. Feagan BG, Fedorak RN, Irvine EJ, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. N Engl J Med. 2000;342:1627-1632.
176. Foster S, Tyler V. Tyler's Honest Herbal. New York, NY: Haworth Press; 1999:97-99.
177. Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer R-JM. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr. 2000;54:514-521.
178. Geerling BJ, Houwelingen AC, Badart-Smook A, Stockbrügger RW, Brummer R-JM. The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn disease and controls. Scand J Gastroenterol. 1999a;34:1108-1116.
179. Geerling BJ, Houwelingen AC, Badart-Smook A, Stockbrügger RW, Brummer R-JM. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol. 1999b;94(2):410-417.
180. Geerling BJ, Stockbrugger RW, Brummer R-JM. Nutrition and inflammatory bowel disease: an update. Scand J Gastroenterol. 1999c;34(suppl 230):95-105.
181. Genser D, Kang M-H, Vogelsang H, Elmadfa I. Status of lipidsoluble antioxidants and TRAP in patients with Crohn's disease and healthy controls. Eur J Clin Nutr.1999;53:675-679.
182. Gionchetti P, Rizzello F, Venturi A, Campieri M. Probiotics in infective diarrhea and inflammatory bowel diseases. J Gastroenterol Hepatol.2000;15:489-493.
183. Glickman RM. Inflammatory bowel disease: ulcerative colitis and Crohn's disease. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:1633-1645.
184. Gupta I, Parihar A, Malhotra P, Singh GB, Ludtke R, Safayhi H, Ammon HPT. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997;2:37-43.
185. Haas l, McClain C, Varilek G. Complementary and alternative medicine and gastrointestinal diseases. Curr Opin Gastroenterol. 2000;16:188-196.
186. Hampe J, Cuthbert A, Croucher JP, et al. Association between insertion mutation in NOD2 gene Crohn's disease in German and British populations. Lancet. 2001; 357:1925-1928.
187. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000;31(1):8-15.
188. Janowitz HD, Croen EC, Sacher DB. The role of the fecal stream in Crohn's disease: an historial and analytical review. Inflamm Bowel Dis. 1998;4(1):29-39.
189. Joachim G. The relationship between habits of food consumption and reported reactions to food in people with inflammatory bowel disease—testing the limits. Nutr Health. 1999;13(2):69-83.
190. Jonas WB, Jacobs J. Healing with Homeopathy: The Doctors' Guide. New York, NY: Warner Books; 1996: 220.
191. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345(15):1098-1104.
192. Kuroki F, Iida M, Matsumoto T, Aoyagi K, Kanamoto K, Fujishima M. Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease. Dig Dis Sci.1997;42(6):1137-1141.
193. Kuroki F, Iida M, Tominaga M, et al. Multiple vitamin status in Crohn's disease. Dig Dis Sci.1993;38(9):1614-1618.
194. Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S. Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol. 1994;19(3):202-205.
195. Levy E, Rizwan Y, Thibault L, et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr.2000;71:807-815.
196. Lewis JD, Fisher RL. Nutrition support in inflammatory bowel disease. Med Clin North Am. 1994;78(6):1443-1456.
197. Lih-Brody L, Powell Sr, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci.1996;41(10):2078-2086.
198. Loudon CP, Corroll V, Butcher J, Rawsthorne P, Bernstein CN. The effects of physical exercise on patients with Crohn's disease. Am J Gastroenterol.1999;94(3):697-703.
199. Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with LactobacillusGG. Ann Nutr Metab. 1996;40:137-145.
200. Msika S, Iannelli A, Deroide G, et al. Can laparoscopy reduce hospital stay in the treatment of Crohn's disease? Dis Colon Rectum. 2001;44(11):1661-1666.
201. Mulder TPJ, Van Der Sluys Veer A, Verspaget HW, et al. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol.1994;9:472-477.
202. Noyer CM, Brandt LJ. Hyperbaric oxygen therapy for perineal Crohn's disease. Am J Gastroenterol.1999;94(2):318-321.
203. Pearson M, Teahon K, Levi AJ, Bjarnason. Food intolerance and Crohn's disease. Gut. 1993;34:783-787.
204. Philipsen-Geerling BJ, Brummer RJM. Nutrition in Crohn's disease. Curr Opin Clin Nutr Metab Care.2000;3:305-309.
205. Rajapakse R, Korelitz BI. Inflammatory bowel disease during pregnancy. Current Treatment Options in Gastroenterology. 2001;4(3):245-251.
206. Rannem T, Ladefoged K, Hylander E, Hegnhøj J, Staun M. Selenium depletion in patients with gastrointestinal diseases: are there any predictive factors? Scand J Gastroenterol.1998;33:1057-1061.
207. Rawsthorne P, Shanahan F, Cronin NC, et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol. 1999;94(5):1298-1303.
208. Ringel Y, Drossman DA. Psychosocial aspects of Crohn's disease. Surg Clin North Am.2001;81(1):231-252.
209. Rioux JD, Daly MJ, Silverberg MS, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet. 2001;29:223-228.
210. Russel MG. Changes in the incidence of inflammatory bowel disease: what does it mean? Eur J Intern Med. 2000;11(4):191-196.
211. Salvatore S, Heuschkel R, Tomlin S, et al. A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in pediatric chronic inflammatory bowel disease. Aliment Pharmacol Ther.2000;14:1567-1579.
212. Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis.2000;6(2):107-115.
213. Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinley MJ. A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med. 2000;342:1633-1637.
214. Steger GG, Mader RM, Vogelsang H, Schöfl R, Lochs H, Ferenci P. Folate absorption in Crohn's disease. Digestion. 1994;55:234-238.
215. Stein RB, Lichtenstein GR, Rombeau JL. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care.1999;2:367-371.
216. Szulc P, Meunier PJ. Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease? [commentary]. Lancet. 2001;357(9273):1995-1996.
217. Takeshima F, Makiyama K, Doi T. Hyperbaric Oxygen as adjunct therapy for Crohn's intractable enteric ulcer. Am J Gastroenterol. 1999;94(11):3374-3375.
218. Talal AH, Drossman DA. Psychosocial factors in inflammatory bowel disease. Gastroenterol Clin North Am.1995;24(3):699-716.
219. Teahon K, Bjarnason I, Pearson M, Levi AJ. Ten years' experience with an elemental diet in the management of Crohn's disease. Gut. 1990;31(10):1133-1137.
220. Tsujikawa T, Satoh J, Katsuhiro U, et al. Clinical importance of n-3 fatty acid-rich diet and nutritional education for the maintenance of remission in Crohn's disease. Gastroenterol. 2000;35:99-104.
221. Ullman D. Homeopathic Medicine for Children and Infants. New York, NY: Penguin Putnam; 1992: 244-245.
222. Ullman D. The Consumer's Guide to Homeopathy.New York, NY: Penguin Putnam; 1995: 76-77.
223. United States Food and Drug Administration (FDA). FDA approves new treatment for Crohn's disease. FDA Talk Paper. October 3, 2001. Number T01-45.
224. United States Food and Drug Administration (FDA) MedWatch. Remicade (infliximab) - Black Box Warning. October 23, 2001. Accessed at http://www.fda.gov/medwatch/SAFETY/2001/safety01.htm - remicaon October 23, 2001.
225. van Heel DA, McGovern DPB, Jewell DP. Crohn's disease: a genetic susceptibility, bacteria, and innate immunity [commentary]. Lancet. 2001;357:1902-1903.
226. Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol. 1995;7:609-614.
227. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease (Cocrane Review). In: The Cochrane Library, 4, 2001. Oxford: Update Software.
228. Zurita VF, Rawls DE, Dyck WP. Nutritional support in inflammatory bowel disease. Dig Dis. 1995;13:92-107.
Good luck, but we all know that you really aren't interested in the truth or having an open mind.
Thank you for those references which I didn't ask for. I specifically asked for references which have been written by yourself. I have not denigrated your treatments because you haven't told me what they are yet. I would love to know - so please tell us.
There are no secrets in medicine, it is supposed to be available to all, nobody has special healing powers. So do give us the benefit of your treatments for say Chron's disease and Ulcerative Colitis so that we can discuss them and see why they are so successful compared with what is currently available.
Download the report from my website. It's not a short answer. That's the purpose of the website, to communicate my protocols to those who wish to read them. You can get an inkling of the treatment from my previous message: re-establish proper beneficial bacteria, identification of any abnormal organisms and their elimination, restoration of proper chemistry, use of digestive enzymes, elimination of dairy, gluten or fructose, Celiac Disease and the identification of food allergies. One patient may have 2-3 of these variables to address, another may have 7-8 of them.
I have no secret healing powers and there are no secrets. I agree. There is a difference in how any physician decides to use information to help their patients. Conventional medicine prefers to mask/manage/suppress symptoms with drugs loaded with side effects and others prefer to attempt to identify the cause of the condition and address that. Pretty simple difference.
Once again, I have no need to write any papers. I am a doctor, not a researcher. The double blind, placebo controlled studies have already been published in reputable journals and their interpretation is up to the individual doctor. I have simply taken the information contained in them and decided to address the findings using natural methods. Conventional medicine will place a Crohn's patient on dangerous anti-inflammatory meds like prednisone, 6-MP, Asacol, Methotrexate, Pentasa, Remicade and doctors like me want to get to the cause of the inflammatory process and eliminate those causes and sit back and watch the patient heal. Again, very simple.
So, I'm through providing you with information. Do the research and open your mind to the possibility of something else out there. Read about me. Google me, I'm all over the place. You can easily read about my protocols from the reports on my website. It's not my job to educate you when it would be so easy for you to find out all about me and my beliefs. I will respond to direct questions or debate about what you have found after reading my information, but not to these inane posts. I will do this for those who are sitting back and watching this foolishness...altho there probably aren't that many paying attention, so it's not worth trying to convince a couple of people when I should have answered the 30-40 emails that have come to me in the past hours that I have been dealing with you.
Read my information and get back to me or let's just stop.
plz shut this thread... i can't stand this publicity whore...
read my book, i get 500 e-mail a hour, read my website, look how much money i made, how little complaints...etc.
it's such blatant advertising...!!!
i don't see why you are bothering to advertise on this site... pretty much everyone on this forum has a very good understanding of biology and should be able to see through any of your nonsense...
and tbh i don't care much about your 'treatments'... if all your doing is giving out suppliments and people are stupid enough to pay a fortune for it then it's their problem not mine...
Revenged says "plz shut this thread... i can't stand this publicity..."
I fully agree. Having been told that "spam" is not allowed, I find this type of self advertising even worse. I am surprised that it is tolerated. In the UK a Physician would be held to account for doing this type of thing.
I was notified by a "Google Alert" that my name was mentioned on this site. What did I find? Amazing that a great testimonial was met by such venom. So, I defended myself. You all are not the first to have shown such a mean spirit. Advertising? Hardly. That's not the goal. I mention my book and websites and the amount of wonderful people who come to me as a way of defending my business model. But you prefer to think those that come to me as fools because you are certainly smarter than they. You guys want to know who I am and what I stand for or do you just want to attack? You have made yourself clear about the type of people you are and how intellectually lazy you are. You have not at any time even slightly attempted to read anything I have written or suggest a patient do about any given condition. Your opinion is that if it isn't medical, it's a scam. Unfortunately, I don't have a natural cure for narrow mindedness. Enjoy yourselves and the "inside the box" world you live in. I'll just carry on without you.
To our old users as well as our new users,
We have indeed been watching this thread that we considered as a possible problem. And the advertisements Mr Dahlman has made were indeed noticed. However, because he was asked for references and proof they were considered as answers to questions and not advertisements. Whether he succeeded in convincing anyone is a different issue. He certainly did not convince me, as there is a difference between publishing an article in a journal and publishing it on your web site. For 10000 dollars i can pay a web designer to make me a website that looks as good as NCBI and says i have found the cure for AIDS. That does not make it true.
To genovese and Revenged
Whether or not the university Dr.Dahlman attended is currently accredited or not is irrelevant if he has a valid legal right to practice his methods. The risks should be evaluated by both patients and the state organization that made him a doctor, as is the case with every other medical doctor. However, until they reach a contrary decision Mr Dahlman is a certified medical doctor and(in my personal opinion) can practice chiropractic and other alternative medicine as he pleases.
To DrDahlman
The "inside the box" thinking that you refer to is what science is. Science is the central dogma to our world, believing that something works just because someones says it does is a long-abandoned paradigm. While science is not inquisition, you need to understand that skepticism is the defining trait of a scientist. It is again my opinion that medicine should not be experimental, and something should not be practiced if it has not been proven to do more good than bad to a patient. However, i have not the vaguest idea of how your methods work, as I am not and will not become a medical doctor. But if they do work as good as you say and you can prove this, and also you want to help as many people as possible with your practices, I suggest you send your articles to medical journals around the world.
That is my final say on the subject, and hope that my intervention on this thread as a moderator will not be required again.
"As a biologist, I firmly believe that when you're dead, you're dead. Except for what you live behind in history. That's the only afterlife" - J. Craig Venter
Re: Sugar Allergy
ok i am allergic to sugar CANE.. so when people talk about a sugar allergy it might be sugar cane.. which is an actual plant. out of all the things i am allergic to sugar cane is one of the worst ones, it makes me really sick. and before i found out i was allergic to it i never thought anyone would be allergic to sugar!
sugar cane or evaporated cane juice is in everything!! but by being allergic to sugar it does not mean glucose, natural sugars, sugar from fruit, literally sugar cane.
but people should know that splenda is made from sugar and if you are allergic to sugar cane you should stay away.. its sometimes written as sucralose on labels
Who is online
Users browsing this forum: No registered users and 1 guest
© Biology-Online.org. All Rights Reserved. Register | Login | About Us | Contact Us | Link to Us | Privacy Policy |


text:
If you had a dollar for every mortgage probe settled over the last five years, you might have a figure close to one of the settlement amounts…well that may be a bit of an exaggeration, but there's no denying the frequency of such settlements has increased dramatically following financial meltdown of the late aughts.
Citigroup becomes the most recent to settle, agreeing on July 14 to fork over $7 billion to the Department of Justice (DOJ) to settle investigations and multiple state and federal lawsuits concerning the questionable residential mortgage backed securities (RMBS) the bank sold on the run up for to the financial crisis.
The settlement is the largest ever extracted under the Financial Institutions Reform, Recovery and Enforcement Act (FIRREA) and will be split between penalties and relief for beleaguered homeowners. $2.5 billion will go to underwater mortgage holders, offering some relief to those affected by the sale of the RMBS, and the remaining $4.5 billion will be taken as civil penalty.
Citigroup will also be required to admit wrongdoing in the issue, a penalty that other banks who have settled similar cases with the DOJ have been able to avoid. The settlement does not prevent the bank or any of its employees from facing criminal charges in relation to the issues.
Related Articles:
Top 10 most expensive discrimination settlements of 2013
JPMorgan Chase's chief compliance officer steps down
BNP Paribas pleads guilty to additional charge; judge satisfied with $9 billion penalty
Attorney General Eric Holder said in a statement that, "the bank's activities contributed mightily to the financial crisis that devastated our economy in 2008."
Commenting on the scope of the issue, U.S. Attorney of the Eastern District of New York Loretta Lynch said, "After nearly 50 subpoenas to Citigroup, Trustees, Servicers, Due Diligence providers and their employees, and after collecting nearly 25 million documents relating to every residential mortgage backed security issued or underwritten by Citigroup in 2006 and 2007, our teams found that the misconduct in Citigroup's deals devastated the nation and the world's economies, touching everyone."
As with similar deals, the settlement dragged on for multiple months as regulators, state officials and bank executives negotiated a potential settlement. Ultimately, the DOJ decided that the potential litigation would be prohibitively expensive for both sides, but felt that the settlement was an appropriate deal to end the pending complaints.

subset: commoncrawl


text:
What the World Needs Now Is Another Flop Singer
Variety reports that the mighty WB network, home to such knee-slapping fare as One Tree Hill and Everwood, is about to unleash an American Idol spoof on the shitty-singing-devouring public.
According to producer Mike Fleiss (who's gifted us with The Bachelor and the millionaireless Who Wants to Marry a Multi-Millionaire), Superstar USA will boot the talented and reward the musically retarded:
"These people believe they're the next pop superstar, even though they're horrible singers...It's not funny seeing bad singers doing karaoke. This is about people who are clearly delusional and watching them butcher song after song."
I'm sorry, I can't remember if I cut that text from the original pitch for American Idol or a Celine Dion press release.


text:
[Trial of device that is not approved or cleared by the U.S. FDA]
This trial has been identified as being associated with a clinical device that has not been approved or cleared by the US Food and Drug Administration. Under the terms of US Public Law 110-85, Title VIII, Section 801, the details of this study are not available to the public.
ClinicalTrials.gov Identifier:
First Posted: December 11, 2009
Last Update Posted: December 11, 2009
Information provided by:
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
|Responsible Party:
|ClinicalTrials.gov Identifier:
|NCT01030588 History of Changes
|Other Study ID Numbers:
PerMIT:Warfarin UofL
R44HL090055 ( U.S. NIH Grant/Contract )
IRB_336.07 ( Other Identifier: IRB )
IRB00000251 ( Other Identifier: IRB )
|First Submitted:
|December 9, 2009
|First Posted:
|December 11, 2009
|Last Update Posted:
|December 11, 2009


text:
Blender is a free 3D animation studio. It includes tools for modeling, sculpting, texturing (painting, node-based shader materials, or UV mapped), UV mapping, rigging and constraints, weight painting, particle systems, simulation (fluids, physics, and soft body dynamics and an external crowd simulator), rendering, node-based compositing, and non linear video editing, as well as an integrated game engine for real-time interactive 3D, and game creation and playback with cross-platform compatibility.
Open Camera is a camera app for Android phones and tablets. It has the option to auto-stabilize so your pictures are perfectly level no matter what. Other features include zoom (multi-touch and single-touch), flash, focus modes, focus and metering areas, face detection, front/back camera, scene modes, color effects, white balance, ISO, exposure compensation, exposure lock, video recording, UHD 4K video, video fps and bitrate control, timer, burst mode, geotagging, configurable volume keys, and choice of save folder. The preview's aspect ratio can be set to either match the display's aspect ratio or the aspect ratio of the photo/video resolution. The UI can be optimised for left or right-handed users.
OpenConnect server (ocserv) is an SSL VPN GNU/Linux server. Its purpose is to be a secure, small, fast, and configurable VPN server which depends on standard protocols like TLS 1.2 and Datagram TLS. It implements the AnyConnect SSL VPN protocol and is compatible with the OpenConnect VPN client (compatibility with other Anyconnect SSL VPN clients is experimental).
DiskScan scans the entire surface of a disk, alerts when a sector is unreadable, and uses the read timing to warn when a sector is having problems. It will tell when a disk has failed and already has bad sectors and also when the disk is near failure and takes too long to read the data.
Strategico is an engine for running statistical analysis over groups of time series. It can manage one or more groups (projects) of time series: by default, you can get data from a database or CSV files, normalize them, and then save them inside the engine. The first statistical analysis implemented inside Strategico is the "Long Term Prediction": it automatically finds the best model that fits each time series. Some of the models implemented are mean, trend, linear, exponential smoothing, and Arima. Strategico is scalable: the statistical analysis over each time series (of a project) can be run separately and independently. It is suggested that you set up an HPC Cluster (High Performance Computing) and/or use a resource scheduler like slurm. It is developed with R, one of the most famous statistical languages.
A tool to retrieve Revelation-stored passwords from the command-line.
The most POSIX compliant and fastest known implementation of a tar archiver.


text:
Inserting cDNA into a retroviral vector?..
Genetics as it applies to evolution, molecular biology, and medical aspects.
Moderator: BioTeam
4 posts • Page 1 of 1
Inserting cDNA into a retroviral vector?..
Hello everyone.
Let's say I have a retroviral vector and its genome consists of single stranded RNA. Is it possible to insert double stranded cDNA into this vector? If yes, what are the processes that need to happen in order to make this occur? And can I use DNA ligase to seal the fragments of cDNA and retroviral vector?
you will hardly insert dsDNA into ssRNA. You have to make RNA from it and that use for the insertion. But you have to be aware whether your retrovirus contains + or - RNA strand.
Cis or trans? That's what matters.
Thank you, but maybe there's another option: could I make the cDNA of the retrovirus using RT-PCR, then insert the cDNA of the gene into the vector, and later insert that vector into dividing cells of another organism? Theoretically, it's the retroviral cDNA that inserts itself into the host chromosomes, so maybe this would work?
4 posts • Page 1 of 1
Who is online
Users browsing this forum: No registered users and 2 guests
© Biology-Online.org. All Rights Reserved. Register | Login | About Us | Contact Us | Link to Us | Privacy Policy |


text:
Alpage Cheesemaking in the Savoie: A Visit with the Burgat Family
The evening light was fading as we ascended the mountain up to the Burgats' alpage home outside of Manigod. With every turn that the car made, the views got even more splendid. Darkening clouds provided a sense of atmosphere and the cool air was deliciously fresh. Pulling up to the Burgats' farmhouse, the sun was just about to disappear and the warm, yellow glow from inside their home was a welcome sight.
Like many in this region of France, the Burgats keep two houses — one lower in the valleys for winter dwelling, and one further up for summer dwelling and pasturing of their animals. At the summer-house, the Burgats make traditional "alpage" cheeses, using the milk of animals grazed at the higher elevations.
Everyone was gathered in the kitchen and it was there that we met Guillaume and Murielle Burgat, along with their children Rémi and Andréa. The inside of the Burgats' house was wonderfully cozy. A wooden table with a vase of beautiful wildflowers served as the centerpiece in the kitchen and an old stove off to one side somehow added to the warmth of the room even though it wasn't on. Rémi had picked the flowers for his mother earlier that day and Murielle told me that they were among the last of the season.
One door off of the kitchen led to a small, immaculately clean cheesemaking room. Murielle, the primary cheesemaker in the family, welcomed us into this room where we were able to watch her go through the evening cheesemaking process. I was interested to learn that it is traditionally the women of the region who make the cheese while the men tend to handle the herds.
Earlier that day, the milk had been heated in a large cauldron-like container and both a starter culture and animal rennet had been added. Left to do its thing, curds had separated from the whey by the time we arrived. Murielle proceeded to take a plastic scoop and break these curds into large pieces. Then, she used a fine, harp-like instrument to break the curds down into even smaller pieces.
This accomplished, the next step in the process was to ladle the curds into the molds. Each mold was lined with cheese cloth and placed on a stainless steel table that had a drain at one end. As Murielle began pouring the curds into the molds, the whey drained off the table into a bucket.
Once all the curds were mounded over the molds, Murielle paused momentarily to give us a taste in a separate little bowl. The curds were warm, slightly spongy and sweet, not having been salted yet. Then, returning to the task at hand, she used her hands to even things out. Mold by mold, she worked her way around the table, gently pressing the curds into the molds, eventually using the cheesecloth to loosen each cheese and flip it over to reinsert it.
Once Murielle had shaped and flipped each cheese, a flat disc was placed on top, followed by a weight. The cheeses were then left to sit overnight and drain further.
I had witnessed this part of the cheesemaking process before but I think what made this time particularly unique and memorable was how it was such an extension of daily life. Previously, I had seen cheesemaking in a work-like environment but here it was very much part of the home experience, how I had always imagined cheesemaking when I read Heidi as a child or, more recently, Adam Bede. Murielle carried on conversing with her family, guests and children while making the cheese. There was also a moment or two of disciplining or comforting as the children got a little rambunctious.
After the cheesemaking was finished, Murielle's husband, Guillaume, took us into their small cave where the tommes are matured before making their journey to a local affineur for additional aging. Then, having seen these tommes progress from curds into molds and finally to the cave, we sat around the Burgat's kitchen table, drank some wine, chatted and sampled a wheel of their cheese with some bread. A pretty perfect evening in my book.
The Burgats make the following cheeses: Reblochon, Manigodine and Tomme de Savoie. Unfortunately, we are unable to import Reblochon to the United States due to current regulations.


text:
Kane County mounts eighth-inning comeback over Beloit
A rocky eighth inning Thursday kept the Beloit Snappers from salvaging a Midwest League series split at Kane County.
The Cougars batted around in the bottom of the eighth, scoring seven runs to come from behind and beat the Snappers 10-8.
Kane County won the final three games of the four-day series.
Beloit piled up six runs over the first three innings and led 7-0 after four.
The Snappers were in cruise control until Kane County plated three runs in the sixth, and they still felt comfortable with an 8-3 lead in the eighth.
There, Kane County's Jacob Rogers led off with a single and scored on Trey Martin's two-run double. Shawon Dunston singled home a run to make it 8-6, and Danny Lockhart's two-run double tied it. Rogers made his second trip to the plate in the inning and hit a sacrifice fly that gave Kane County the lead.
Stuart Pudenz couldn't get an out in the eighth and gave up four earned runs to suffer the loss. Tyler Bremmer struck out six and walked one in three innings of relief for the Cougars to move to 2-0.
Beloit opens a three-game series at Burlington today.
Last updated: 11:05 pm Thursday, April 24, 2014


text:
Merger and acquisition deals are notoriously glacial in their progression, but after being proposed seven months ago, the acquisition of Nokia Corp.'s handset operations by Microsoft Corp cleared a major hurdle on April 7 and is one step closer to completion.
The Chinese Ministry of Commerce has given the deal the go-ahead following Microsoft's agreement to comply with a list of licensing conditions. Many of those conditions relate to patent protection for Android phone manufacturers. As the home of many Android manufactures, China has a vested interest in the legal and copyright dispute-free production of Android devices.
That agreement will last for up to eight years, and relates to up to 200 types of patent families that Microsoft will gain access to with the deal. Google has previously pushed China to ensure the deal would not push licensing agreement costs higher, but Nokia argues that its copyright practices have never been predatory. It used the announcement as an opportunity to drive that point home.
"No authority has challenged Nokia's compliance with its … undertakings related to standard-essential patents or requested that Nokia make changes to its licensing programme or royalty terms," Nokia said in a statement on Tuesday.
In offloading its handset manufacturing operations to Microsoft, Nokia will be able to focus on its networking and OEM subsections. In the process, Microsoft hopes to bolster its struggling smartphone presence against giants like Apple and Google.
In an interview in the November 2013 edition of InsideCounsel, Microsoft General Counsel Brad Smith said that the Microsoft-Nokia deal, "gives us the chance to add a business that is complementary to our own … transitioning us from a pure software company to a devices and services company."
While Nokia has been faced tax disputes relating to its operations in India, all other regulatory issues have been cleared at this point and the deal is expected to move forward. The original deal was proposed in September 2013, for roughly $7 billion.
For more on licensing deals check out these stories:
Nokia and HTC settle suits and pen cross-licensing agreement
Google and Samsung sign cross-licensing agreement


text: Looking for some of the nastiest and freshest nude mom sex pictures on the web? Well, look no further because we have tons of naked mom xxx galleries for you to stick your cock into. Don't waste your time browsing through dosens of free mature porn sites since we bring all the naughty action right here! If you have a special appetite for beauty older women and horny mature milfs or Moms Skirt Pics, then Hot Moms Pussy will surely land in your bookmarks. Make sure to cum back often because we deliver sexy moms porn photos on a regular basis!


text:
Peter J. Saldana, Janesville, WI (1935-2014)
December 20, 1935 - February 23, 2014
Peter J. Saldana, age 78, of Janesville, died on Sunday, Feb. 23, 2014, at Cedar Crest Health Care Center. He was born in Janesville, on Dec. 20, 1935, and raised by his adopted parents, the late Carmen and Mercedes (Rodergues) Saldana. On May 5, 1962, at St. Joseph Catholic Church in Fort Atkinson, he married Janet May Ells and together they had two children. She predeceased him on Jan. 17, 2013. Over the years, Peter worked at the former Dana Mfg., Highway Trailer, Dorsey Trailer and Trek Bicycle. Peter was a very likable and outgoing person, with a great sense of humor, who made friends with everyone he met. He enjoyed going camping, grilling out, taking trips to the casinos and watching western movies. Janet was Peter's inspiration in life. He took pleasure in singing, dancing, and spending time with her and he missed her dearly when she died.
Peter is survived by his two children, Yolanda (Robert) Sandmire of Janesville, and Carmen (YooMi) Saldana of Janesville/Huntington, IN; two grandchildren, whom he was very proud of, Thomas and Sarah Saldana. He is further survived by his sister, Maria Louise Chacon of Elk Grove, IL; several brothers and sisters-in-law; nieces; nephews; other relatives; and his faithful dog, Cha Cha. In addition to his wife and parents, he was predeceased by his sister, Carmen Tolson; and two brothers, Joe Saldana and John Hernandez.
Funeral services will be held at 1 p.m. on Monday, March 3, 2014, at the WHITCOMB-LYNCH FUNERAL HOME with Fr. Stephen Umhoefer officiating. Burial will follow at Milton Lawns Memorial Park. Visitation will be on Monday from 11 a.m. until the time of the service at the FUNERAL HOME.
Whitcomb - Lynch Funeral Home & Cremation Services
21 S. Austin Road, Janesville, WI (608) 752-2444


text:
Kittensplosion Sweatshirt
Kittensplosion Sweatshirt
orig: $79.95
Sale Price: $52.46
This sweatshirt is made with Pre-Shrunk 2-Way Stretch 100% Premium Microfiber Polyester and hand-finished to ensure your graphic is aligned, complete, and totally brilliant. Machine wash as much as you like - our sweatshirts undergo sublimation printing that utilizes a special heat-dye application that resists fading and bleeds.
Comfort & Style
Pre-Shrunk 2-Way Stretch 100% Premium Microfiber Polyester. This fabric is incredibly strong and durable as well as resistant to wrinkles, shrinking, abrasion, and mildew. Machine washable and easy to care for.
Vivid & Original 360 Design
High-definition sublimation printing technique covers the entire front, back, sleeves... everything! Each fabric panel of the sweatshirt is printed with the graphics before sewing to ensure the design is flawless and the construction is perfect.
Quality - Hand Made in the USA
Each sweatshirt is created and hand-finished in the USA. High construction quality with great attention to detail ensures it won't ever fade, crack, or peel!
Design covers the front and back of this product.
Our return policy is effective for 30 days. To be eligible for a return, your item must be unused, in the same condition that you received it, and it must also be in the original packaging. Sorry, no returns on orders under $20. We'll do anything we can to help get you the exact item you need.
Refunds (if applicable) If you would like to return your item, please send an email to email@example.com
If you would like to cancel a made to order item(s) for which the order was placed 3 or more days prior you will be charged a 15% cancellation fee on account of the cost we incur for the item already being in production. Please make sure to read our item descriptions carefully to verify whether you are purchasing a made-to-order or ready to ship item.
Exchanges (if applicable) We only replace items if they are defective, damaged, or need a size replacement. If you need to exchange it for the same item, send an email to email@example.com


text:
David Daniel "Mo" Moses, Edgerton, WI (1947-2014)
May 27, 1947 - January 29, 2014
David Daniel "Mo" Moses, 66, of Edgerton, passed away on Wednesday, Jan. 29, 2014, at Mercy Hospital, with his loving family by his side, after his second occurrence with cancer. He was born on May 27, 1947, in Black River Falls, WI, son of the late Arthur and Rachael (Simplot) Moses. He was united in marriage on Feb. 20, 1988, to Janell Stewart in Fort Wayne, IN. David owned and operated Mo's pub in Edgerton, for many years. He attended Black River Falls High School. He enjoyed fishing with his grandchildren, playing cards, hunting, restoring old cars and his loving dog, Nickers.
David is survived by his loving wife of 31 years of togetherness, Jan of Edgerton; two daughters, Terrie (Shawn) Duhr of Milton, and Danelle (Chris) Belz of Edgerton; five grandsons: Zachery, Cameron, Austin, Owen and Landon; a father to Bradley (Bernadene) Kuschel of Milton; papa to Ella and Ian; one brother, Tom Moses of Black River Falls; mother-in-law, Sis Stewart of Janesville; two brothers-in-law, Dan (Cheryl) Stewart of Milton, and Jeff (Rhonda) Stewart of Janesville; one niece and nephew.
Friends may call at the EHLERT FUNERAL HOME AND CREMATION SERVICES, US HWY 51 S, Edgerton, on Saturday, Feb. 1, 2014, from 11 a.m. until 1 p.m. A celebration of Mo's life will be held at the DECOY BAR AND GRILL, immediately following. In lieu of other expressions of sympathy, memorials may be made to the American Cancer Society in Mo's name. Condolences may be expressed at ehlertfuneralhome.com


text:
Theories - Origin of Life
Discussion of everything related to the Theory of Evolution.
Moderator: BioTeam
Re: Theories - Origin of Life
What I wrote (the above)in my last post is a direct quote from Ernst Mayr himself in his lecture of 1999
You will find that lecture here
http://www.biologie.uni-hamburg.de/b-on ... luence.htm
One of the founding fathers of the modern synthesis proudly hails Darwinism as a philosophy.
You are now taking on Ernst Mayr, well good for you.
Phylosophy is the intellectual persuit of truth. Science is a rather recent and far more effective tool than the biased hand waving(and coersion) of the past. Scottie, stop the evasions,long winded obfuscations and name dropping. Just explain your theory.
Re: Theories - Origin of Life
The context has not changed any meaning.
Here is what he went on further to say in the same lecture
my emphasis.
No context change here at all.
Ernst Mayr was simply being honest and indeed proud of it.
Evolutionary theory is not a physical science it is a philosophy that is being promoted as a physical science.
Re: Theories - Origin of Life
You posted
Ok let's put that statement to the test
Craig Venter and his team made headlines when they announced their success in transforming and existing cell into a cell with as he put it "with no biological anscester"
He published an account of what his team accomplished in the Science Express portion of the journal Science. Here is an excerpt from the 12-page report.
They made this long DNA molecule by putting together smaller segments of commercially available DNA which they purchased from Blue Heron. They purchased pieces that were about 1,000 base pairs long and joined ten of them together to form pieces that were about 10,000 base pairs long. They took ten of these 10,000 base pair pieces and joined them together to form pieces about 100,000 base pairs long. Finally, they joined eleven of these 100,000 base pair pieces together to form the complete molecule.
In other words they designed and built a new genome and inserted this genome into the cell of another bacterium and it booted up.
As he says
Now take any number of biologists and examine that cell. Make sure they have no information about how that cell came about. We know that it was clearly designed and built(or at least an important part of it was).
Now just for clarity here is your statement again
So please explain to me but more importantly to this forum, how these biologists by only using the tools of science can determine who the designer and creator of this new species is.
If science can do that, then you should have no problem demonstrating it.
Please prove me wrong.
Sounds like Craig Venter was the designer in this case. I'm pretty sure you can't extrapolate that very far. Craig Ventor is human, he was engaged in a scientific exploration, and I doubt that he has created any other life. (Being a scientist he wouldn't keep it a secret.)
Now back to your designer. WHO? WHAT? WHEN? WHERE? hell I am even curious about WHY? Inquiring minds want to know.
By the way, if your apponant in an arguement gets tired, annoyed,exasperated and decides argueing with you is pointless, it doesn't mean you have won the arguement. This is a common misconception among crackpots. Crackpots believe that when people politely nod and smile that they are aggreeing with the ranting. It just means that they know a crackpot when they see one and know that it can be dangerous to provoke the delusional. Don't be a crackpot.
Re: Theories - Origin of Life
No NO it doesn't sound like Craig Venter. It was Craig Venter and his team.
And how do we know that Venter is the designer?
Because he has provided an historical record, or has that simple point escaped your notice.
Without that record we would not know who created it.
We would not know by examining the cell itself with all the science at our disposal.
As I have said before and repeatedly, neither I nor any other person could tell who created the cell without some form of authentic historical record, any more than could you tell who designed and made this cell without an historical record to accompany it.
Surely even you with all your intelligence can understand that, can't you?
As for me, well I am just a crackpot aren't I, so how could I possibly explain such simple concepts to you.
I'm having trouble seeing what this experiment says about your designer.
I recall you were at one time hung up on the idea that creating a new species was not possible. Even though it's just a bacteria it is a new species, lab created. Just like the lizards.Two proofs of concept.
It seems your designer hasn't been doing anything metaphysical, just physical and well within the pervue of science.
Sooooooo, once more Please describe your theoretical designer.
If you evade this question once more I will give up on you and you will no doubt conclude (incorrectly) that you have won this arguement.
Re: Theories - Origin of Life
Well there you go, rambling again. (bad sign)
However let's try and unravel your confusion.
You really must not rely on your powers of recall, a very uncertain process. Go and read my posts again. It really isn't that difficult, it is in English.
It does seem that you have some difficulty with language. I need to take that into account in future. Very remiss of me, please accept my apologies.
Where have I stated or even relied on anything metaphysical?
In fact I have been arguing that the metaphysical is within your argumentation and therefore not physical science.
Oh come come, I don't need to conclude anything. You reveal it all for yourself far better than I could ever conclude.
I will of course try and educate if you wish to continue. Patience is a virtue I have tried to develop over many years now, so don't worry you won't be in any danger of trying my patience, honest.
Re: Theories - Origin of Life
Please back up this absurd statement.
Also, I take issue with your consistent mischaracterizations of what the literature, you yourself have linked in this thread, actually say.
Shapiro could reference 56 or 560,000,000,000 papers. So what? This is from a lecture at a conference, is speculative, is NOT a peer reviewed scientific work. On top of this blatant appeal to authority, you (and other ID'ers) have totally overstated what Shapiro is saying in this document, which Shapiro himself is overstating. There is nothing earth shattering in the actual science he is referencing in this document.
It's a common tactic for creationists/intelligent design proponents to latch on to this particular document as if it totally disproves random mutation in favor of design claims. I back that statement up by simply pointing out that if search for Shapiro's "third way" concept you find it plastered all over many psuedoscientific ID websites.
You have terribly mischaracterized this paper. In no way does this work refute common ancestry. It's an attempt to reestablish the shape of the "tree of life", or even redefine it in other terms, to match the observational data. NOWHERE in the paper does the author even remotely suggest throwing out the idea of common ancestry.
This Biological Big Bang argument in no way supports design claims. The peer reviewers, however, saw the potential for this work to be misinterpreted (intentionally or otherwise).
Allow me to quote:
Your design claims are not science. Wish as though you might, they just aren't. Design infers a designer. You admit science can't find the designer. Therefore design claims are not science. Stop claiming they are.
You also repeatedly allude to "Darwinists" and try repeatedly to make the claim that Darwinian evolution is a religion. This a tired old debate tactic of the Creationist/Intelligent Design community. It's a way to try to equate the two (religion and the study of evolution by natural processes) even though are clearly not the same thing.
Evolution is not a religion. Your evidence that it is a religion is the zeal and conviction with which it is pursued. This logic could be applied to ANY activity, for example quilting or coin collecting. Calling evolution a religion makes religion pretty much meaningless.
The fact is, people of diverse cultural backgrounds and religious affiliations believe in evolution, yet not one of them, if asked, would identify their religion as evolution. If evolution is a religion, it is the only religion that is rejected by all its members.
About your design claims:
1) There is no "theory of design" in biology because design can't be defined in the normal sense without also defining an agent and purpose. A theory of design must address agent and purpose or it is not about design. You admit that you do not define the agent and purpose. Therefore, even if you could somehow prove design, it wouldn't be about design in the usual sense at all.
2) Nowhere in the scientific literature is any design theory validated.
3) The design claim is useless and unscientific, it has not generated any predictions and no scientific work has come from it.
scottie, you can go on linking scientific works and mischaracterizing until your heart's content but you'd still be wrong WRONG wrong. All throughout this thread you've made this argument from incredulity about design. The problem with your arguments is that they rely on "disproving" evolution instead of proving positive your own claims. You appear to be trying to sneak in the god of the gaps whether you admit or not.
Re: Theories - Origin of Life
This is an absurd attempt to discount Darwinian evolution by misconstruing Mayr. Shame on you scottie. Shame.
The effects of Darwin's ideas on Philosophy and the founding of the well regarded science of Philosophy of Biology is clearly the sentiment of Mayr's article. Not writing off Darwinian evolution as something less than scientific or as a something akin to religion.
Mayr is giving praise to Darwin's theories not solely as philosophical, but in addition to it's merit as scientific FACT. Huge difference when you compare it to what you are inferring he meant scottie.
Further down in Mayr's article:
"No educated person any longer questions the validity of the so-called theory of evolution, which we now know to be a simple fact." Sounds a heck of a lot different than what you wrote in your post right above the one I'm criticizing:
Darwinian evolution is not a religion. Did you just not understand Mayr, or were trying to intentionally misconstrue him? Either way your point is invalid and wrong.
Darwin created the theory of the origin of new species from the former by means of natural selection. The theory of evolution - "from simple replicators to the crown of evolutionary selection", he did not create, and just trying to adjust to his theory of the origin of species.
The theory of evolution before Darwin came up as a "whipping boy", embed it in biology and used to criticize the science of being a missionary.
Darwin's theory works seamlessly with the theory of Devolution from the initial complex engineering design to dead-end species.
http://translate.google.com/translate?h ... ro.name%2F
Who is online
Users browsing this forum: No registered users and 1 guest
© Biology-Online.org. All Rights Reserved. Register | Login | About Us | Contact Us | Link to Us | Privacy Policy |


text:
The Obama administration told asset managers last week that it was planning additional sanctions against Russia over the conflict in Ukraine.
Officials from the Treasury Department and the National Security Council met in Washington with mutual-fund and hedge-fund managers, according to a person who attended. Their comments sent a message that more sanctions are on the way and that investors, if they were concerned about the impact, should manage that risk, said the person, who asked not to be identified because the discussions weren't public.
The meeting, convened a week before talks with Russia in Geneva that ended yesterday, left managers grappling with the question of whether the government intended to follow through, or was trying to trigger asset sales through the threat of sanctions, said the person. Former administration officials have said forcing Russia out of global financial markets is the strongest tool President Barack Obama has at his disposal in trying to defuse the crisis between Russia and Ukraine.
"A lot of firms on the buy side have cut their exposure to Russia," Jack Deino, the head of emerging-market debt at Atlanta-based Invesco Ltd., said in an interview, talking about the industry in general.
Staff of the National Security Council, which is the president's main forum for considering national security and foreign policy matters, has reached out to businesses to provide information on sanctions against Russia, said Laura Lucas Magnuson, a spokeswoman for the council.
"As Russia continues to destabilize Ukraine, we are prepared to sanction additional individuals and entities, and we've made clear that we'd be prepared to target certain sectors of the Russian economy if we see a significant escalation including direct Russian military intervention in eastern Ukraine," she said. "We are coordinating our actions closely with our partners in Europe and the G7."
The four-way talks on the crisis in Ukraine ended with an accord, after Russian President Vladimir Putin said he hopes he won't have to send in troops. Stocks in Russia and Asia rose. U.S. Secretary of State John Kerry said Russia, which the U.S. and its European allies accuse of stoking the conflict, must start implementing the deal within days or face additional sanctions.
The 'Biggest Weapon'
"If we're not able to see progress on the immediate efforts, to be able to implement the principles of this agreement this weekend, then we will have no choice but to impose further costs on Russia," Kerry said at a press conference.
Investors had been selling Russian securities, causing its currency to fall 7.6 percent against the dollar this year. The country's reaction to the ouster of President Viktor Yanukovych in February—annexing the Crimea region and amassing troops by the Ukraine border—has increased the perception of risk attached to investing in Russian sovereign debt.
The cost to protect $10 million of debt through the credit default swap market has risen to $248,000 annually for five years from $166,000 at the end of last year, according to data provider CMA, a unit of McGraw Hill Financial Inc.
An administration official warned this week that if the talks fail, the U.S. is ready to take further steps, targeting people in the Russian president's inner circle and entities they oversee. Industry-specific sanctions are also an option, according to the official, who spoke about private talks on condition of anonymity.
"The biggest weapon in terms of sanctions would be similar sanctions to what we did in Iran and basically try to exclude Russia from international financial markets," said William Pomeranz, deputy director of the Kennan Institute for Advanced Russian Studies of the Woodrow Wilson Center in Washington. "The Russians fear that, and that is what the Russians want to avoid."
The meeting in Washington last week included several mutual-fund companies with large bond units, according to the person. Separately, the U.S. Securities and Exchange Commission (SEC) has been asking U.S. asset managers about their investments in Russian securities, said the person.
An administration official, who asked for anonymity to discuss internal deliberations, said there have been no specific requests made to investors not to invest in Russia. The official said the Department of Commerce and the Treasury do have conversations with the business community to explain what they're doing, such as briefing executives after a sanctions announcement. The official said the government maintains open lines of communication so businesses understand what policy makers are doing.
Hillary Clinton, a former U.S. secretary of state, said this month that the global economic market is doing its part to rein in Putin.
"The flood of money out of Russia in the last several months has been astonishing, and I hope it continues," Clinton said April 8 at a conference in San Francisco. "That is the best way to undermine the oligarchs who support him, undermine his own economic interests."
'Wake-Up Call'
One bond manager at a large U.S. mutual-fund company, who asked not to be named citing company policy, said the firm has been working to sell Russian debt and wasn't inclined to return to the market in the near future. The person, who hadn't heard of any government attempts to influence money managers, said the company perceives risk in Russia as having increased significantly.
"This is a real wake-up call that there are, in the former Soviet Union, still a lot of moving parts and more risk than meets the eye," said Deino at Invesco, a mutual-fund manager with $787 billion in assets as of March 31. "This is going to result in a decisive increase in the cost of doing business in Russia, in the risk premium, and that's not going to go away for years."
Deino is the lead manager of the Dublin-registered Invesco Emerging Markets Bond Fund, which holds $255 million.
Western Asset Management, the bond investing unit of Legg Mason Inc., has been making "incremental" purchases of Russian assets that are less exposed to sanctions, Robert Abad, who helps oversee about $53 billion of emerging-market debt at Western, said in a telephone interview.
"It's all about the sensitivity of each sector to potential sanctions," said Abad, who favors telecommunications and mining. "No one is here to gamble. We all have a fiduciary responsibility to asses risk in the most prudent way."
The Geneva statement called for all illegal armed groups in Ukraine to be disarmed, seized buildings to be returned to their legitimate owners and occupied public places to be vacated. An amnesty will be granted to protesters. A mission from the Organization for Security and Cooperation in Europe will help oversee the measures. A new constitutional process will aim to establish "a broad national dialogue."
Russia's Micex Index increased 2.2 percent at 3 p.m. in Moscow, and the Ukrainian Equities Index rose 0.9 percent. The MSCI Asia Pacific Index added 0.3 percent. The yield on Russia's February 2027 bond slid 18 basis points to 8.99 percent, while the ruble retreated after its biggest gain this month yesterday. Financial markets in the U.S., U.K., Germany, Hong Kong and Australia are among those closed for a holiday.


text:
no repeat sequences in exons of genes?
Genetics as it applies to evolution, molecular biology, and medical aspects.
Moderator: BioTeam
6 posts • Page 1 of 1
no repeat sequences in exons of genes?
Okay the other day in my genetics class we went over basically how there are alot of repeat sequences everywhere in the genome, even introns. Examples we talked about were microsatellites (dispersed everywhere which are short sequences), dna transposons such as SINES and LINES, alpha satellite repeats in centromeres, telomerase repeats at the end of chromosomes, and some others. I know that sometimes LINES can use reverse transcriptase to insert a mRNA back into DNA and cause diseases but nowhere in my book did it mention what would happen if a repeat sequence would be put into an exon. My theory would be that if inserted into the exon the repeat sequence would cause a frameshift mutation and cause problems with the splicing and the proteins made would be incorrect. The repeated sequence would not code for proteins so would the ribosome just skip over this during translation? Is this the major reason why or is there a bigger reason that I am missing. Thanks for any guidance!
the inserted mRNA is long (at least several hundreds of bases), thus the insertion doesn't cause frame shift, but gene knock-out, since the cell is not able to translate it correctly.
Cis or trans? That's what matters.
okay, well this is a really good question at last.
one of the greatest theories in genetics is the origin of introns in eukaryotic DNA. They may have multiple origins. My favored idea, and it is the only sensible one I have heard, apart from the one I came up with on a previous post but have only just come to appreciate in answering this question, is that these retroelements (themselves derived from retroviruses and/or the founders of retroviruses) jumped in to the genome, and interuppted the genes. The cells which survived had to learn to unsplice these viruses, but rather than doing it at the genome level, it was done at the transcriptome level (mRNA). This had advantages as well as the obvious disadvantages, hence evolution took its course.
Don't forget the introns are the bits that end up on the cutting room floor, in mRNA terms.
Re: no repeat sequences in exons of genes?
Dude, its sooo much more likely that the mRNA so retrotransposed would lead to the creation of an extra locus for the gene of interest.....remember its very unlikely to hit a piece of protein coding DNA, due to the fact that introns are way way way bigger than exons - 10-100x bigger at least in most cases i estimate. In fact there are pseudogenes in the human genome which are very strong evidence of this type of evolution.
http://ukpmc.ac.uk/abstract/MED/8111117 ... C365C5C17E
well, that would cause disease!
that is the 67% probability for sure.
most likely event is the gene would be a mutant phenotype- either a 'genetic knockout' or it may function as a wrong-un; probably would take some getting used to depends on the gene, the exon (a lot of coded DNA has redundant function - an argument in favour of evolution being more like a river finding its way to the sea than directed by an engineer or a God, although correction of deleterious mutations like this may be done by a God, I am not sure of the evidence yet) hence if it goes in in the correct frame, then it may not cause any problems (hypothetically, at least).
it might code for viral proteins, or gobbledeegook polypeptides. In fact you should have been told that these transposons often encode their own enzymes such as reverse transcription polymerase, although such proteins-coding sequences are often a mess due to mutations - for jumping the gene only needs to have jumping signals to jump - the transposase can be provided by say a viral infection or another transposon which ironically may have mutations in its jump-signal DNA which mean it CANT jump!
Once the transposon is in the genes exon, well the other answers cover it I think .
BUT ... in case not: the ribosome would try to read it - it would NOT just skip over it! if it was at the first exon, it might take over entirely with the first start codon, or its rival start codon might compete for the ribosome thus decreasing protein production. If it had stops (stop codons) , then that would be the end of the protein synthesis at that first stop codon, unless amber/opal/ochre tRNA's are considered (phew!), or unlikely editing by APOBEC family...(!). If it had no stop codons whatsoever (very unlikely), then a readthru into the 'real' exons of the gene would ensue, and function ...who knows the impact. As for transposon proteins, if they are still intact, then there would be a 1/3 chance of a correct reading frame x1/2 chance that it was in the right direction multiplied by the number of encoded proteins in the transposon - If you consider that a retrovirus from which they evolved has many protein-coding sequences (like HIV... env gag nef pol rev tat vif vpr vpu 9 protein coding genes producing >9 proteins via alternative splicing). So one could anticipate that such transposon (broken viral) genes would be incorporated quite often when exons are hit, which as i say is rare, but remember there are some 1-100x10^12 cells per human body! So rare events happen in you probably every day, at a wild guess. What is important is to have a healthy immune system which will kill off these cells, before they become transformed into cancer cells, which is the usual outcome of a new uncontrolled protein. And remember, as each such creation is novel, and made by your'self', the difficult question is how the immune-system can tell which is which.
As a vision, one could see a rare transposon jumping into an active gene, and hijacking its machinery, making its own transposases in enormous amounts, and this causing cancer as the entire genome is blitzkreiged by genes leaping in and out at random. The immune system would be overrun. Evolution pressure by a single gene. Amazing.
Incidentally, you may have heard of RAG1 and RAG2, which splice genomic DNA to make the T cell receptors and B cell receptors. They evolved from such transposases, when we were all jawless hagfish-like.
6 posts • Page 1 of 1
Who is online
Users browsing this forum: No registered users and 0 guests
© Biology-Online.org. All Rights Reserved. Register | Login | About Us | Contact Us | Link to Us | Privacy Policy |


text:
Our Views: Janesville must move cautiously on landfill decision
News in The Gazette that Janesville might sell or close its landfill likely shocked many residents.
It shouldn't be a shock, however, that the city council met in closed session in January to discuss these ideas. Disturbing, yes, but not shocking, as we've been down this road of questionable secrecy before.
Many readers can't remember a time when the city wasn't in the landfill business. Other cities and companies have dumped their trash here for years. No, it doesn't make sense to let outsiders fill our landfill too quickly, nor dump toxins that might someday leach into Janesville's groundwater, no matter how carefully workers line holes with clay. Still, a landfill can be a valuable asset. A city with its own landfill doesn't pay another municipality or company for a place to dump its garbage—or for the fuel to haul it elsewhere.
That could be a key concern as the city explores whether to close or sell the landfill, which is running deficits. In the April 23 s Gazette, however, Operations Director John Whitcomb tried to reassure residents.
First, he said he couldn't foresee a day when the city stops curbside trash pickup. Second, he hopes to keep demolition and compost services open to residents. Third, he pointed out that few cities own landfills. He doesn't think residents would see much difference in trash service if the city sold the landfill because the city would try to negotiate reasonable disposal prices with the new owner.
For years, the landfill generated revenue that paid for most or all of the city's curbside trash collection. Whitcomb says that's no longer the case. In 2011, the city started charging each home $56 annually to collect trash. That fee almost doubled this year. To some residents, the fee is as offensive as a ripe bag of garbage in mid-August.
Many outside haulers, however, have stopped coming here, eroding tipping-fee revenue as operating costs rise. In January, the city lost another big customer when a company that owns its own landfill bought out Sherman Sanitation. Whitcomb says that with private companies consolidating and contracts typically covering several years, he's not optimistic about attracting more haulers.
Selling or closing the landfill, he says, would help the city avoid borrowing money to open future cells or close current ones.
Whitcomb says selling rather than closing the landfill is the better idea, and that seems to make sense. Still, officials must assure residents that a long-term deal with a company wouldn't cause the city's trash collection fees to rise.
While closing the landfill might eliminate big future expenses, officials would need to consider costs to cap it and how to pay off debt already incurred. Besides, can the city project how much rising gas prices might push up costs to truck our trash elsewhere?
One more consideration: If the city closes or sells the landfill, what happens to future landfill space created as a sand and gravel company keeps digging nearby?
"Part of our doing this is we don't know what the value is to the private sector," Whitcomb says of seeking requests to purchase the landfill. "We've never gone down this road. The council wanted to find out."
That, too, seems to make sense. But rather than burying concerns like so much rubbish, the city must provide reasonable answers to questions. The city should give residents plenty of chances to comment and lean on the side of transparency as it weighs options for this potentially monumental shift in operations.
If residents must pay more for trash collection and the landfill, maybe that's the best option. It's great that the landfill once paid for itself, but no one says it must. It's a city service. Services cost money. If it turns out that paying more and keeping control of our landfill is the best option, so be it.